Cytotoxic molecule mRNA expression in chronically rejected human kidney allografts

A Nocera1, A Tagliamacco, A Ferrante

  • 1Transplant Immunology Unit, San Martino Hospital, Genoa, Italy. nocera@hsanmartino.liguria.it

Transplantation Proceedings
|September 27, 2005
PubMed

Insights

Chronic kidney allograft nephropathy (CAN) involves cytotoxic T cells. Analysis revealed cytotoxic molecules in rejected kidney grafts, suggesting cellular and humoral mechanisms contribute to CAN.

Area of Science:

  • Nephrology
  • Immunology
  • Transplantation

Background:

  • The exact causes of chronic kidney allograft nephropathy (CAN) are not fully understood.
  • Both immunological and non-immunological factors contribute to CAN.
  • The role of cytotoxic T cells in CAN pathogenesis requires further investigation.

Purpose of the Study:

  • To investigate the potential involvement of alloreactive cytotoxic T cells in CAN.
  • To analyze the expression of cytotoxic molecules in kidney allografts with and without CAN.

Main Methods:

  • Surgically removed kidney grafts were analyzed from two groups: CAN cases (n=10) and non-CAN controls (n=3).
  • Semiquantitative reverse transcription polymerase chain reaction (RT-PCR) was used to detect the transcription of cytotoxic molecules like granzyme B and perforin.
  • Expression levels of Th2-type cytokines (IL-10, IL-3, IL-6) were also assessed.

Main Results:

  • Granzyme B transcripts were found in 70% (7/10) of CAN grafts, and perforin in 90% (9/10).
  • Cytotoxic molecule expression was not linked to acute graft injury signs.
  • No cytotoxic molecules were detected in the non-CAN control group (n=3).
  • CAN grafts also showed Th2-type cytokine transcripts (IL-10, IL-3, IL-6).

Conclusions:

  • Explanted chronically rejected kidney allografts express cytotoxic molecule transcripts.
  • These findings suggest that both cellular (cytotoxic T cells) and humoral alloreactive mechanisms are implicated in CAN pathogenesis.
  • Further research into these mechanisms could inform strategies to prevent or treat CAN.

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...